Semglee

Product manufactured by Mylan Specialty L.p.

Application Nr Approved Date Route Status External Links
BLA210605 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Semglee Is Indicated To Improve Glycemic Control In Adults And Pediatric Patients With Type 1 Diabetes Mellitus And In Adults With Type 2 Diabetes Mellitus. Limitations Of Use Semglee Is Not Recommended For The Treatment Of Diabetic Ketoacidosis. Semglee Is A Long-Acting Human Insulin Analog Indicated To Improve Glycemic Control In Adults And Pediatric Patients With Type 1 Diabetes Mellitus And In Adults With Type 2 Diabetes Mellitus. ( 1 ) Limitations Of Use Not Recommended For Treating Diabetic Ketoacidosis. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Insulin Glargine

Comments